共 170 条
[1]
Hargrove JW(2010)Mortality among HIV-positive postpartum women with high CD4 cell counts in Zimbabwe AIDS 24 F11-4
[2]
Humphrey JH(2013)Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the option B + approach Curr Opin HIV AIDS 8 474-89
[3]
Ahmed S(2009)Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies Lancet 373 1352-63
[4]
Kim MH(2011)Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 493-505
[5]
Abrams EJ(2016)Antiretroviral therapy for the Prevention of HIV-1 transmission N Engl J Med 375 830-9
[6]
Sterne JA(2007)Effectiveness and safety of simplification therapy with once-daily tenofovir, lamivudine, and efavirenz in HIV-1-infected patients with undetectable plasma viral load on HAART HIV Clin Trial 8 328-36
[7]
May M(2018)Optimizing prevention of HIV mother to child transmission: duration of antiretroviral therapy and viral suppression at delivery among pregnant malawian women PLoS ONE 13 e0195033-S55
[8]
Costagliola D(2017)Viral suppression and HIV Drug Resistance at 6 months among women in Malawi’s option B+ program: results from the PURE Malawi Study J Acquir Immune Defic Syndr 75 S149-3
[9]
de Wolf F(2017)Rate, correlates and outcomes of repeat pregnancy in HIV-infected women HIV Med 18 440-97
[10]
Phillips AN(2015)Determinants and experiences of repeat pregnancy among HIV-Positive kenyan Women–A mixed-methods analysis PLoS ONE 10 e0131163-42